Solventum Corporation

Fundamentals5.0
Price Action7.0
News Sentiment8.0
AI Rating
6.0

Key Drivers

  • Margin Compression
  • Tight Liquidity
  • High Intangibles

AI
AI Summary

6.0

SOLV has shifted from a simple earnings beat story to a strategic re-rating setup, where the Health Information Systems separation could unlock value if management sustains 9.5% organic growth and converts it into durable margin and FCF expansion—but thin liquidity, compressed margins, and one-off quarter benefits make execution the real test.

Catalyst
ExecutionRisk
MedTech‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Margin Compression
  • Tight Liquidity
  • High Intangibles

SOLV remains reasonably valued and historically very profitable, but the latest quarter showed a steep margin decline and tighter liquidity, making near-term balance-sheet risk the key concern.

mixed
liquidity

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Breakout Hold
  • Dip Recovery
  • Near-Term Resistance

Over the last month, SOLV recovered from a sharp mid-period dip, broke above early-August resistance near $88.1, and stays constructive as long as it holds above $88.6.

bullish
neutral
Support Level: $83-$85
Resistance Level: $88.6

Sharp drop on 2026-08-06 to 2026-08-07, then a steady rebound

Sentiment & News

8.0

Key News Insights:

  • Beat-and-Raise
  • Spin-off Plan
  • Backlog Growth

Solventum and SOLV Energy both delivered strong results with raised outlooks, while Solventum advanced a Health Information Systems spin-off to sharpen its core MedTech focus.

earnings
restructuring

This is broadly positive for the instrument, as improving execution, stronger demand, and strategic simplification support outlooks despite some remaining cost and timing risks